🔗 Permalink

Assignee profile:

Ipsen Pharma S.A.S.

City:

Boulogne

Country:

France

Published Applications:

Last publication date:

2015-05-28

Patent Grants:

Last grant date:

2017-03-28

Top Inventors for applications by Ipsen Pharma S.A.S.

These are the the leading inventors for applications assigned to Ipsen Pharma S.A.S.:

Zheng Xin Dong 23 Holliston, MA United States
Michael DeWitt CULLER 5 Hopkinton, MA United States
Jacques-Pierre MOREAU 4 Upton, MA United States
Yeelana SHEN 3 Franklin, MA United States

Sun H. Kim 2 Needham, MA United States
John S. Eynon 2 Bellingham, MA United States
Giovanni Tulipano 2 Cusago, Italy
SUN HYUK KIM 2 NEEDHAM, MA United States

Andrea Giustina 2 Brescia, Italy
Daniel B. DEOLIVEIRA 2 Bellingham, MA United States
Kevin Zhou 2 Mansfield, MA United States
Michael D. Culler 2 Hopkinton, MA United States

Yeelana SHEN 1 McKinney, TX United States
John E. Taylor 1 Somerville, MA United States
Jonh E. Taylor 1 Somerville, MA United States
Barry Morgan 1 Franklin, MA United States

David H. Coy 1 New Orleans, LA United States
Barry A. Morgan 1 Franklin, MA United States
Thomas D. Gordon 1 Medway, MA United States
William Murphy 1 Slidell, LA United States

YEELANA SHEN 1 FRANKLILN, MA United States
Rakesh Datta 1 Brookline, MA United States
Christophe Alain Thurieau 1 Paris, France
Ipsen Pharma, S.A.S. 1 Boulogne-Billancourt, France

Jundong Zhang 1 Newton, MA United States
Jeanne Mary COMSTOCK 1 West Boylston, MA United States

Recent patent applications by Ipsen Pharma S.A.S.

Ipsen Pharma S.A.S. based in Boulogne, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-05-28 ✅ Patent 9,603,942 granted on 2017-03-28

US20150148522A1

Human necessities

Somatostatin-dopamine chimeric analogs

#2 | 2014-05-01 ✅ Patent 8,952,128 granted on 2015-02-10

US20140121354A1

Chemistry; metallurgy

Somatostatin-dopamine chimeric analogs

#3 | 2013-05-16 ✅ Patent 8,859,729 granted on 2014-10-14

US20130123170A1

Chemistry; metallurgy

Growth hormone releasing peptides

#4 | 2012-05-24 ✅ Patent 8,741,835 granted on 2014-06-03

US20120129767A1

Human necessities

Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment

#5 | 2012-02-16 ✅ Patent 8,440,611 granted on 2013-05-14

US20120040885A1

Chemistry; metallurgy

Analogues of neuropeptide Y having at least one synthetic amino acid substitution

#6 | 2012-01-12 ✅ Patent 8,877,715 granted on 2014-11-04

US20120010154A1

Chemistry; metallurgy

Cytotoxic conjugates having neuropeptide Y receptor binding compound

#7 | 2011-06-30 ✅ Patent 8,871,706 granted on 2014-10-28

US20110160133A1

Human necessities

Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue

#8 | 2011-06-16 ✅ Patent 9,072,703 granted on 2015-07-07

US20110144007A1

Chemistry; metallurgy

Glucose-dependent insulinotropic polypeptide analogues

#9 | 2011-06-09 ✅ Patent 9,074,014 granted on 2015-07-07

US20110136733A1

Human necessities

Analogues of glucose-dependent insulinotropic polypeptide

#10 | 2010-11-04 ✅ Patent 8,039,435 granted on 2011-10-18

US20100279922A1

Chemistry; metallurgy

Melanocortin receptor ligands

#11 | 2010-09-16 ✅ Patent 8,404,804 granted on 2013-03-26

US20100234564A1

Chemistry; metallurgy

Methods and intermediates for chemical synthesis of polypeptides and proteins

#12 | 2010-07-15 ✅ Patent 8,324,386 granted on 2012-12-04

US20100179304A1

Chemistry; metallurgy

Somatostatin-dopamine chimeric analogs

#13 | 2010-05-06 ✅ Patent 8,236,762 granted on 2012-08-07

US20100113367A1

Chemistry; metallurgy

Peptide-cytotoxic conjugates

#14 | 2009-11-05 ✅ Patent 8,299,022 granted on 2012-10-30

US20090275511A1

Chemistry; metallurgy

Analogs of ghrelin substituted at the N-terminal

#15 | 2009-11-05 ✅ Patent 8,178,651 granted on 2012-05-15

US20090275501A1

Chemistry; metallurgy

Somatostatin-dopamine chimeric analogs

#16 | 2009-10-08 ✅ Patent 9,133,262 granted on 2015-09-15

US20090253638A1

Chemistry; metallurgy

Somatostatin antagonists

#17 | 2009-09-17 ✅ Patent 8,349,797 granted on 2013-01-08

US20090232838A1

Chemistry; metallurgy

Ligands of melanocortin receptors

#18 | 2009-08-06 ✅ Patent 7,977,455 granted on 2011-07-12

US20090197802A1

Chemistry; metallurgy

Analogues of GLP-1

#19 | 2009-06-25 ✅ Patent 8,076,281 granted on 2011-12-13

US20090163416A1

Human necessities

Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment

#20 | 2009-06-18 ✅ Patent 8,258,094 granted on 2012-09-04

US20090156483A1

Chemistry; metallurgy

Analogs of ghrelin

#21 | 2009-05-21 ✅ Patent 8,138,218 granted on 2012-03-20

US20090131478A1

Chemistry; metallurgy

Growth hormone secretagogues

#22 | 2008-10-02 ✅ Patent 8,377,865 granted on 2013-02-19

US20080242619A1

Chemistry; metallurgy

Growth hormone releasing peptides

#23 | 2008-07-24 ✅ Patent 7,691,859 granted on 2010-04-06

US20080176835A1

Chemistry; metallurgy

Prenyl transferase inhibitors

#24 | 2008-05-08 ✅ Patent 8,138,305 granted on 2012-03-20

US20080108566A1

Chemistry; metallurgy

Analogues of GLP-1

#25 | 2006-09-21 ✅ Patent 7,811,989 granted on 2010-10-12

US20060211610A1

Chemistry; metallurgy

Peptide YY analogs

AssigneeID:

425175 ⎘